James E. Shmerling serves as Executive at Biostage, Inc., where they oversee executive responsibilities. Since joining the company, James E. Shmerling has executed 2 insider transactions totaling $129.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 21, 2023 involved purchasing 6,864 shares valued at $29.9K.
James E. Shmerling currently holds 23,756 shares of Biostage, Inc. (BSTG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Shmerling has been a net buyer of BSTG stock. They have purchased $129.9K and sold $0 worth of shares.
James E. Shmerling's most recent insider trade was on Aug 21, 2023, when they purchased 6,864 shares at $4.35 per share.
Get notified when new Form 4 filings are submitted
| $5.92 |
| Discretionary |